ENVALITH
株式会社ハーバー研究所 logo

HABA LABORATORIES,INC.

4925Standard MarketChemicals

株式会社ハーバー研究所 logo
HABA LABORATORIES,INC.4925

Cosmetics Business (Single Segment)

Manufacturing and sales of cosmetics and health foods based on an unwavering commitment to additive-free formulation

PeriodCurrentPreviousChange
Sales (Consolidated, FY2026 ending March 2026)¥12,141 million¥12,062 million
Operating Profit (Consolidated, FY2026 ending March 2026)¥727 million¥590 million
Ordinary Profit (Consolidated, FY2026 ending March 2026)¥708 million¥609 million
Profit Attributable to Owners of Parent (Consolidated, FY2026 ending March 2026)¥760 million¥577 million
Operating Margin (FY2026 ending March 2026)6.0%4.9%
Equity Ratio (End of FY2026 ending March 2026)76.2%72.3%
Earnings Per Share (Consolidated, FY2026 ending March 2026)¥201.07¥152.47
Cash and Cash Equivalents, Period-End Balance (FY2026 ending March 2026)¥5,684 million¥4,744 million
Sales (Full-Year Forecast, FY2027 ending March 2027)¥12,800 million¥12,141 million
Operating Profit (Full-Year Forecast, FY2027 ending March 2027)¥610 million¥727 million

Business Details

The manufacturing and sales business of cosmetics and health foods operated by the Haba Laboratories Group, founded in 1983. All products thoroughly adhere to the "Five Additive-Free" principle, excluding paraben preservatives, petroleum-based surfactants, synthetic fragrances, mineral oil, and tar-based dyes. While Mail Order (Including EC) Channel serves as the primary channel, sales are also conducted through four routes: Wholesale to Department Stores & Directly-Operated Stores (Store Sales Business), Other Wholesale, and directly-operated stores. The company has built an integrated system spanning R&D, manufacturing (both in-house within the group and outsourced), logistics, and sales. Domestic sales account for over 90% of the total, while overseas expansion continues, focused primarily on the Chinese and broader Asian markets.

Recent Overview

Profit structure reforms bore fruit, driving a 23.4% increase in operating profit; the following fiscal year is expected to see a profit decline due to upfront investments

In FY2026 (ending March 2026), sales were largely flat at ¥12,141 million (up 0.7% year on year), but fixed cost reductions from closing four unprofitable stores and suspending operations at and selling the Komoro plant, along with optimized inventory management and a 1.9% reduction in SG&A expenses (¥7,359 million), contributed to operating profit of ¥727 million (up 23.4% year on year) and net profit of ¥760 million (up 31.9% year on year). A gain of ¥132 million on the sale of fixed assets related to the Komoro plant sale was also recorded as extraordinary income. For FY2027 (ending March 2027), sales are projected to reach ¥12,800 million (up 5.4% year on year), while upfront investments in customer base expansion, product development, and IT are expected to result in a significant profit decline, with operating profit of ¥610 million (down 16.1% year on year) and net profit of ¥470 million (down 38.2% year on year). As a subsequent event, effective April 1, 2026, the company absorbed Haba Cosmetics Co., Ltd. through merger, establishing an integrated operational structure spanning logistics through sales.

Key Products

product
Basic Cosmetics (Skincare)

A skincare line centered on the serum "Yakuyo White Lady" and the lotion "G Lotion," among others. Sales for FY2026 (ending March 2026) reached ¥7,475 million (up 0.3% year on year). A renewal effort is progressing that includes reorganizing the lineup by specific skin concerns.

product
Health Foods & Sundries, etc.

A category centered on health foods and beauty supplements. Sales for FY2026 (ending March 2026) reached ¥2,440 million (up 1.7% year on year). The company is accelerating the development and launch of new foods with function claims and beauty supplements to broaden its customer base.

product
Makeup Cosmetics

Sales for FY2026 (ending March 2026) reached ¥955 million (down 2.8% year on year). While this category, along with toiletries (¥644 million, down 5.2%), is trending downward, other cosmetics (such as campaign set items) performed well at ¥627 million (up 14.5% year on year).

platform
Mail Order (Including EC) Channel

Sales for FY2026 (ending March 2026) reached ¥6,867 million (down 2.5% year on year). While sales from the premium tier (Diamond and Platinum members) increased, this was offset by a decline in sales from the basic tier (Friend and Standard members) stemming from a decrease in new customer acquisitions. The company is responding through strengthened F2 conversion measures resulting from revisions to the Club Haba program and enhanced digital promotion.

service
Wholesale to Department Stores & Directly-Operated Stores (Store Sales Business)

Wholesale to department stores reached ¥1,932 million (up 8.7% year on year), remaining solid against a backdrop of recovering inbound demand. Directly-operated stores shrank to ¥447 million (down 26.7% year on year) following the closure of four unprofitable stores and the relocation/renewal of three stores. The store sales business overall totaled ¥2,378 million (down 0.3% year on year).

service
Other Wholesale (Domestic & Overseas)

Sales for FY2026 (ending March 2026) reached ¥2,895 million (up 10.1% year on year). Overseas, shipment volumes increased due to improved sales efficiency from consolidating Chinese distributors. Domestically, results were affected by store closures among major clients and a decrease in large-lot orders. The rollout of products exclusive to self-selection channels has also begun.

Growth Drivers

  • Continued recovery of inbound demand in wholesale to department stores (up 8.7% year on year to ¥1,932 million in FY2026 ending March 2026)
  • Improved sales efficiency in overseas wholesale through consolidation of Chinese distributors (Other Wholesale overall up 10.1% year on year to ¥2,895 million)
  • Improved profit structure through closure of unprofitable stores and sale of the Komoro plant (SG&A expenses down 1.9%, ¥132 million gain recorded on sale of fixed assets)
  • Increased sales and improved LTV among the premium tier (Diamond and Platinum members) resulting from revisions to the Club Haba program
  • Strengthened digital promotion targeting the millennial generation (including video content through collaborations with creators)
  • New development and launch of foods with function claims and beauty supplements, and the start of rollout of products exclusive to self-selection channels
  • Development of new customer segments and sales channels through the launch of a new brand for general distribution ahead of FY2027 (ending March 2027)
  • Improved management efficiency through integrated logistics and sales operations following the absorption merger of Haba Cosmetics (April 2026)

Risks

  • Declining trend in new customer acquisition in mail order (the resulting decline in sales from the basic tier directly contributed to the primary channel's 2.5% year-on-year decline)
  • Suppressed purchasing among the basic tier (Friend and Standard members) due to rising prices and heightened cost-consciousness
  • Forecast of a significant profit decline in FY2027 (ending March 2027) due to upfront investment (operating profit of ¥610 million, down 16.1% year on year; net profit of ¥470 million, down 38.2% year on year)
  • Intensifying competition in the EC market and rising advertising costs and customer acquisition costs (CPA)
  • Declining sales in Other Wholesale (Domestic) due to store closures among major domestic wholesale clients and a decrease in large-lot orders
  • Risk of procurement constraints for key raw materials such as squalane and Chishima bamboo grass water (due to fishing restrictions, environmental changes, etc.)
  • Impact on inbound demand and overseas business from prolonged geopolitical risk and exchange rate fluctuations
  • Risk of personal information leakage (given the large volume of customer information held due to the mail-order-centric business model)
  • Risk of additional impairment of fixed assets (the company recorded an impairment loss of ¥1,576 million in FY2024 (ended March 2024))

Last updated: June 19, 2026